tiprankstipranks
Trending News
More News >
Affimed N.V. (GB:0HL9)
:0HL9
UK Market
Advertisement

Affimed (0HL9) Share Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

0HL9 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Affimed
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0HL9 Stock 12 Month Forecast

There Are No Analyst Ratings for GB:0HL9 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0HL9 Financial Forecast

0HL9 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

0HL9 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on GB:0HL9
Wells Fargo
Wells Fargo
$11$0.1
Hold
400.00%
Upside
Downgraded
05/14/25
Affimed's Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Cantor Fitzgerald Analyst forecast on GB:0HL9
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
05/14/25
Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
Leerink Partners Analyst forecast on GB:0HL9
Leerink Partners
Leerink Partners
$5$0.39
Hold
1850.00%
Upside
Downgraded
05/14/25
Affimed's Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on GB:0HL9
Wells Fargo
Wells Fargo
$11$0.1
Hold
400.00%
Upside
Downgraded
05/14/25
Affimed's Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Cantor Fitzgerald Analyst forecast on GB:0HL9
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
05/14/25
Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
Leerink Partners Analyst forecast on GB:0HL9
Leerink Partners
Leerink Partners
$5$0.39
Hold
1850.00%
Upside
Downgraded
05/14/25
Affimed's Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Affimed

1 Month
xxx
Success Rate
2/5 ratings generated profit
40%
Average Return
-2.74%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -2.74% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
-19.08%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -19.08% per trade.
1 Year
Yale JenLaidlaw
Success Rate
2/5 ratings generated profit
40%
Average Return
-9.10%
reiterated a buy rating a year ago
Copying Yale Jen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -9.10% per trade.
2 Years
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
-29.38%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -29.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HL9 Analyst Recommendation Trends

Rating
Sep 24
Nov 24
Dec 24
Jan 25
May 25
Strong Buy
6
5
9
9
7
Buy
9
9
5
2
1
Hold
3
10
16
18
15
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
24
30
29
23
In the current month, 0HL9 has received 8 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. 0HL9 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

0HL9 Stock Forecast FAQ

What is GB:0HL9’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0HL9’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0HL9, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Affimed N.V. a Buy, Sell or Hold?
      Currently, no data Available
      What is Affimed N.V.’s share price target?
      Currently, no data Available
      What do analysts say about Affimed N.V.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Affimed N.V.?
      To buy shares of GB:0HL9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis